The pathogenic mechanisms that underlie Parkinson's disease remain unknown. Here, we review evidence from both sporadic and genetic forms of Parkinson's disease that implicate both mitochondria and oxidative stress as central players in disease pathogenesis. A systemic deficiency in complex I of the mitochondrial electron transport chain is evident in many patients with the disease. Oxidative stress caused by reactive metabolites of dopamine and alterations in the levels of iron and glutathione in the substantia nigra accompany this mitochondrial dysfunction. Recent evidence from studies on the genetic forms of parkinsonism with particular stress on DJ-1, parkin, and PINK-1 also suggest the involvement of mitochondria and oxidative stress.
Introduction
In 1817, Dr. James Parkinson of London published his Essay on the Shaking Palsy (Parkinson, 2002) . Parkinson defined a disorder that was characterized by an involuntary resting tremor, a stooped posture, weakness of the limbs, and a festinating gait with little to no cognitive deficits. Today, we recognize this disorder as being characterized clinically by four cardinal symptoms; resting tremor, rigidity, bradykinesia (slowness of movement), and postural instability.
A profound depletion of the neurotransmitter dopamine (DA) in the striatum is the primary cause of these motor symptoms, collectively known as parkinsonism. Parkinson's disease (PD) is the main cause of parkinsonism and generally presents as parkinsonism along with varying extrastriatal effects such as gastrointestinal, olfactory, and sleep disorders. Because the symptoms of PD can vary widely
